Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,837 total articles
Ellomay Capital Ltd., a renewable energy and power project developer operating across Europe, the USA, and Israel, announced the filing of its Annual Report on Form 20-F for the year ended December 31, 2025. The report reflects some financial adjustments including reductions in project development costs and tax benefits compared to previously annou…
AH Realty Trust (NYSE: AHRT) completed the sale of its construction business for $2.4 million, marking a significant step in its strategic transformation. This move simplifies the company's business model and aligns with its objective to focus on operating a high-quality retail and office real estate portfolio, aiming for long-term shareholder valu…
Hudbay Minerals announced record first quarter 2026 financial results including record revenue of $757.3 million and adjusted EBITDA of $421.9 million. The company reaffirmed 2026 production and cost guidance across its diversified copper, gold, zinc, and silver operations in Peru, Manitoba, and British Columbia. Hudbay also advanced key growth pro…
BrightSpring Health Services, a NASDAQ-listed provider of home and community-based health services, announced strong Q1 2026 financial results with a 25.6% increase in net revenue to $3.6 billion, a 44.8% rise in adjusted EBITDA to $190 million, and net income growth from $9 million to $74 million year-over-year. The company completed the divestitu…
LyondellBasell has finalized the sale of selected European olefins and polyolefins assets to AEQUITA, marking a key milestone in its European strategic reassessment aimed at concentrating on high-return assets and enhancing financial flexibility. The divestiture includes facilities in France, Germany, the UK, and Spain but retains operations in Tar…
Magna International Inc. reported strong first quarter 2026 financial results, with a 3% increase in sales to $10.4 billion and a 58% increase in adjusted EBIT to $558 million. Despite a reported loss due to asset sale-related charges, the company demonstrated improved operational efficiency, expanded margins, and robust free cash flow. Magna is ma…
Oculis Holding AG will present significant late-stage clinical updates at the ARVO 2026 Annual Meeting, including final patient visits completed in its Phase 3 DIAMOND program for diabetic macular edema (DME) with OCS-01 eye drops, with topline results expected in June 2026. The company also shared promising neuroprotective data for Privosegtor in …
The Magnum Ice Cream Company N.V. announced a transaction where the Chief Financial Officer, Abhijit Bhattacharya, acquired 20,000 ordinary shares on the Amsterdam Stock Exchange. This insider purchase reflects confidence in the company but does not indicate major strategic changes.
NIO Inc. delivered 29,356 vehicles in April 2026, marking a 22.8% year-over-year increase, and achieved a cumulative total of over 1.1 million vehicles delivered. The company set a delivery record for its All-New ES8 model and commenced pre-sales for its flagship ES9 SUV and ONVO's new L80 SUV, signaling robust growth and innovation in the premium …
McEwen Inc. announced the successful closing of its previously announced business combination with Golden Lake Exploration Inc., consolidating Golden Lake’s Jewel Ridge projects with McEwen’s existing Windfall and Lookout Mountain discoveries in Nevada’s Eureka Mining District. This acquisition is expected to extend the life and enhance the value o…
Li Auto Inc. announced April 2026 vehicle deliveries of 34,085 units, pushing cumulative deliveries to 1.67 million. The company showcased the all-new Li L9 Livis at the 2026 Beijing International Automotive Exhibition, with its official market launch scheduled for May 15. Li Auto continues to expand its retail and charging infrastructure across Ch…
Senseonics Holdings, Inc., a medical technology company specializing in implantable continuous glucose monitoring systems, announced an $80 million underwritten public offering of common stock and pre-funded warrants. The proceeds are intended to support the launch of their Eversense 365 system, advance pipeline products, and cover general corporat…
Rein Therapeutics, a clinical-stage biopharmaceutical company, announced the pricing of a $50 million underwritten public offering of common stock to fund the completion of its Phase 2 clinical trial of LTI-03 for idiopathic pulmonary fibrosis and support general corporate purposes. The offering includes 50 million shares at $1.00 each, with an opt…
Taseko Mines Limited announced it will release its first quarter 2026 financial results after market close on May 6, 2026, followed by a conference call and webcast on May 7 to discuss the results with investors and analysts.
Helus Pharma has announced a collaboration with TARA Mind to support recruitment for its HLP003 Phase 3 clinical trial targeting Major Depressive Disorder and to expand mental health outreach within veteran communities. This partnership aligns with the recent Executive Order focused on accelerating treatments for serious mental illnesses, particula…
California Water Service Group (NYSE: CWT) received final approval from the California Public Utilities Commission on its 2024 General Rate Case and Infrastructure Improvement Plan. The CPUC authorized rate increases over three years and $1.45 billion in investments to upgrade water infrastructure ensuring safe, reliable water service and supportin…
Gran Tierra Energy Inc. announced it will release its 2026 first-quarter financial and operating results on May 7, 2026, followed by a conference call on May 8. The company also provided details about its 2026 Annual Meeting of Stockholders, which will be held virtually on May 8, 2026. The announcement includes instructions for shareholder particip…
Hemab Therapeutics Holdings, a clinical-stage biotech company focused on innovative therapies for blood coagulation disorders, announced the pricing of its upsized initial public offering (IPO) of 16.75 million shares at $18.00 per share. The common stock will begin trading on Nasdaq under ticker symbol COAG, with gross proceeds expected at approxi…
NOVONIX Limited has finalized the sale of its NOVONIX Battery Technology Solutions Inc. business in Canada to its former CEO. This divestiture aligns with NOVONIX's strategic focus on building a vertically integrated synthetic graphite supply chain in North America to support domestic battery industry growth. The transaction involved a $1 sale pric…
TransAlta Corporation held its 2026 Annual and Special Meeting of Shareholders with solid participation. All nine director nominees were elected by large majorities. The appointment of Ernst & Young LLP as auditors, approval of the executive compensation approach, and an increase in shares available under the Share Unit Plan were all approved by sh…
InterCure Ltd. announced its 2025 financial results reporting over NIS 270 million in revenue, a 13% increase over 2024, a net loss of NIS 37 million, and a significant 90% increase in Adjusted EBITDA to NIS 47 million, marking the twelfth consecutive half-year of positive Adjusted EBITDA. The company resumed operations at its Nir Oz facility after…
Ring Energy, Inc., a US-based oil and gas company focusing on Permian Basin operations, announced it will release its first quarter 2026 earnings after market close on May 6, 2026, followed by a conference call on May 7 to discuss results.
Silynxcom Ltd., a tactical communication headset manufacturer, announced its 2025 full-year financial results, highlighting $5.8 million in revenues and maintaining strong profitability with a gross profit of $2.1 million. The company strengthened its financial position through a $2.9 million capital raise in 2025 and ended the year with $2.98 mill…
YD Bio Limited, a Nasdaq-listed biotechnology company, announced a 17% increase in net revenue for 2025 driven by pharmaceutical sales growth and product launches. Despite revenue gains, net loss widened due to increased operating expenses from research and development and business expansion. The company advanced its therapeutics and diagnostics pi…
FibroBiologics announced its Q1 2026 financial results, highlighting progress in its phase 1/2 clinical trial for diabetic foot ulcers with CYWC628, positive preclinical results in burn and degenerative disc disease programs, a $3M fundraise, and regained Nasdaq compliance. The company also expanded its patent portfolio and plans to initiate furthe…
